Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimicrobial resistance in staphylococci

B M Moreira1, R S Daum

  • 1Department of Pediatrics, University of Chicago, Illinois, USA.

Pediatric Clinics of North America
|June 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meticillin-resistant Staphylococcus aureus (MRSA) update: New insights into bacterial adaptation and therapeutic targets.

Journal of global antimicrobial resistance·2016
Same author

Quality of antenatal care as a risk factor for early onset neonatal infections in Rio de Janeiro, Brazil.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases·2015
Same author

Longitudinal surveillance for meningitis by Acinetobacter in a large urban setting in Brazil.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2013
Same author

The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2012
Same author

Severe infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumannii.

Transplant infectious disease : an official journal of the Transplantation Society·2011
Same author

A case of severe pancreatitis complicated by Raoultella planticola infection.

Journal of medical microbiology·2007
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
Same journal

Insurance Hurdles for Laser Authorization in Pediatric Patients.

Pediatric clinics of North America·2026
Same journal

Controversies in Increasing the Pipeline for Pediatric Dermatology.

Pediatric clinics of North America·2026
See all related articles

Staphylococci exhibit diverse molecular mechanisms to resist antibiotics like beta-lactams. Limited treatment options exist for methicillin-resistant staphylococcal infections, with no new antibiotics on the horizon.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Staphylococci are clinically significant pathogens known for developing antibiotic resistance.
  • Antimicrobial resistance in staphylococci poses a major threat to public health.
  • Existing treatment options for resistant staphylococcal infections are becoming increasingly limited.

Purpose of the Study:

  • To review the molecular mechanisms of antibiotic resistance in staphylococci.
  • To highlight the challenges in treating infections caused by resistant staphylococci.
  • To discuss the future outlook for antibiotic development against staphylococcal infections.

Main Methods:

  • Literature review of studies on staphylococcal antibiotic resistance.
  • Analysis of molecular mechanisms conferring resistance.

Related Experiment Videos

  • Evaluation of current and future therapeutic strategies.

    • Main Results:

    • Staphylococci employ a wide range of molecular mechanisms to resist various antibiotics, including beta-lactams.
    • Methicillin-resistant staphylococci present significant treatment challenges due to limited therapeutic options.
    • The pipeline for novel antibiotics effective against resistant staphylococci, particularly concerning glycopeptide resistance, is currently insufficient.

    Conclusions:

    • Staphylococcal antibiotic resistance is driven by diverse molecular strategies.
    • Effective treatment of resistant staphylococcal infections requires a deeper understanding of resistance mechanisms.
    • Urgent development of new antimicrobial agents is crucial to combat the growing threat of staphylococcal infections.